CN101550152A - 一种头孢克洛化合物及其制法 - Google Patents
一种头孢克洛化合物及其制法 Download PDFInfo
- Publication number
- CN101550152A CN101550152A CNA2009100149829A CN200910014982A CN101550152A CN 101550152 A CN101550152 A CN 101550152A CN A2009100149829 A CNA2009100149829 A CN A2009100149829A CN 200910014982 A CN200910014982 A CN 200910014982A CN 101550152 A CN101550152 A CN 101550152A
- Authority
- CN
- China
- Prior art keywords
- cefaclor
- solution
- purification
- compound
- water mixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960005361 cefaclor Drugs 0.000 title claims abstract description 60
- -1 Cefaclor compound Chemical class 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 22
- 238000010521 absorption reaction Methods 0.000 claims abstract description 16
- 239000000243 solution Substances 0.000 claims abstract description 14
- 239000011347 resin Substances 0.000 claims abstract description 10
- 229920005989 resin Polymers 0.000 claims abstract description 10
- 239000012043 crude product Substances 0.000 claims abstract description 9
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- 239000013078 crystal Substances 0.000 claims abstract description 8
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 4
- QYIYFLOTGYLRGG-GPCCPHFNSA-N cefaclor Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 QYIYFLOTGYLRGG-GPCCPHFNSA-N 0.000 claims abstract 10
- 238000000746 purification Methods 0.000 claims description 16
- 239000003463 adsorbent Substances 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000002425 crystallisation Methods 0.000 claims description 8
- 230000008025 crystallization Effects 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000005352 clarification Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 5
- 239000003480 eluent Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 239000003929 acidic solution Substances 0.000 claims description 4
- 239000003637 basic solution Substances 0.000 claims description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 3
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 2
- 238000011001 backwashing Methods 0.000 claims description 2
- 239000003610 charcoal Substances 0.000 claims description 2
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 claims description 2
- LKHYFCSSVZVVNF-UHFFFAOYSA-N ethyl hexanoate;sodium Chemical compound [Na].CCCCCC(=O)OCC LKHYFCSSVZVVNF-UHFFFAOYSA-N 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 235000011056 potassium acetate Nutrition 0.000 claims description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 2
- 235000015320 potassium carbonate Nutrition 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 claims description 2
- 229960004418 trolamine Drugs 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000012670 alkaline solution Substances 0.000 abstract 1
- WKJGTOYAEQDNIA-IOOZKYRYSA-N (6r,7r)-7-[[(2r)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate Chemical compound O.C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 WKJGTOYAEQDNIA-IOOZKYRYSA-N 0.000 description 34
- 238000005261 decarburization Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- 108010087702 Penicillinase Proteins 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 206010062255 Soft tissue infection Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940047526 cephalexin monohydrate Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- YGZIWEZFFBPCLN-UHFFFAOYSA-N n,3-bis(2-chloroethyl)-4-hydroperoxy-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine Chemical compound OOC1CCOP(=O)(NCCCl)N1CCCl YGZIWEZFFBPCLN-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 229950009506 penicillinase Drugs 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Landscapes
- Cephalosporin Compounds (AREA)
Abstract
本发明涉及一种头孢克洛化合物及其制法，该方法是将现有技术制备的头孢克洛粗品，经过以下步骤制备得到相对纯的头孢克洛化合物：向头孢克洛粗品中加入碱性溶液，调节pH值至8－10，充分反应至澄清，得头孢克洛盐溶液，然后经大孔吸附树脂吸附，吸附完全后，用洗脱剂洗脱头孢克洛盐，收集洗脱液，加活性炭吸附，过滤，滤液加入酸性溶液，调节pH值至3－4，析出结晶，过滤，洗涤，干燥，得头孢克洛晶体。
Description
技术领域
本发明涉及一种头孢克洛化合物的精制方法，属于医药技术领域。
背景技术
头孢克洛，其化学名称为：(6R，7R)-7-[(R)-2-氨基-2-苯乙酰氨基]-3-氯-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-甲酸一水合物，分子式为：C15H14ClN3O4S·H2O，分子量：385.83，结构式为：
为半合成第二代β-内酰胺类抗生素，对于革兰氏阳性菌有较强的抗菌活性，对产青霉素酶金黄色葡萄球菌、A组溶血性链球菌、草绿色链球菌和表皮葡萄球菌的活性与头孢羟氨苄相同，对不产酶金黄色葡萄球菌和肺炎球菌的抗菌作用较头孢羟氨苄强2～4倍。对革兰阴性杆菌包括对大肠埃希菌和肺炎克雷伯菌等的活性较头孢氨苄强，与头孢羟氨苄相仿，对奇异变形杆菌、沙门菌属和志贺菌属的活性较头孢羟氨苄强。临床上主要用于由敏感菌所致呼吸系统、泌尿系统、耳鼻喉科及皮肤、软组织感染等。
在美国专利US3925372中公开介绍了头孢克洛的制备方法，将7-ACCA经N，O-双-三甲硅基乙酰胺保护，与苯甘氨酸甲基钠盐和氯甲酸甲酯形成的混酐反应制得。J.Med.Chem.，18：403，1975.中头孢克洛的合成，使用7-ACCA的对硝基苄基酯为起始原料，最后需要通过头孢克洛酯的水解得到头孢克洛产品，总收率约50％。在美国专利US5608055中公开了头孢克洛的合成工艺，采用7-ACCA为原料，经过酰化缩合、水解得到头孢克洛的盐酸盐水溶液，在此溶液中加入DMF制得头孢克洛DMF复合物，头孢克洛DMF复合物经转化得到头孢克洛原料药。上述专利合成的头孢克洛通常含有高于头孢克洛重量0.5％的苯甘氨酸，和高于头孢克洛重量0.3％的7-ACCA，获得的头孢克洛纯度较差，杂质较多，采用普通的介质吸附的方法，例如活性炭吸附法，并不能从根本上除去上述杂质，而且还会吸附头孢克洛原料。
发明内容
本发明的目的在于克服现有技术存在的缺点，提供一种头孢克洛化合物的精制纯化方法，从根本上大大提高了头孢克洛的纯度，保证了制剂的质量。
本发明提供的头孢克洛化合物的精制方法，该方法是将现有技术制备的头孢克洛粗品，经过以下步骤制备得到相对纯的头孢克洛化合物：向头孢克洛粗品中加入碱性溶液，调节pH值至8-10，充分反应至澄清，得头孢克洛盐溶液，然后经大孔吸附树脂吸附，吸附完全后，用洗脱剂洗脱头孢克洛盐，收集洗脱液，加活性炭吸附，过滤，滤液加入酸性溶液，调节pH值至3-4，析出结晶，过滤，洗涤，干燥，得头孢克洛晶体。
上述所述的精制方法，碱性溶液为能和酸发生反应的有机碱、固体碱式盐或无机碱的水溶液，可以为氨水、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、碳酸氢钠、碳酸氢钾、乙酸钠、乙酸钾、乙基己酸钠、三乙胺、二异丙基乙基胺、三丁胺、三乙醇胺、二甲基苄基胺。
上述所述的精制方法，大孔吸附树脂为聚苯乙烯吸附树脂及其衍生树脂，优选为Hz816吸附树脂或AmberliteXAD-4吸附树脂。
上述所述的精制方法，洗脱剂为低碳有机溶剂-水混合液，选自甲醇-水混合液、乙腈-水混合液、丙酮-水混合液、乙醇-水混合液或异丙醇-水混合液，优选为体积比为1∶1的异丙醇-水混合液。
上述所述的精制方法，酸性溶液为能和碱发生反应的有机酸或无机酸的水溶液，选自盐酸、磷酸、硝酸、硫酸、柠檬酸、甲酸、乙酸溶液。
上述所述的精制方法，析出结晶过滤后用乙醇洗涤，40-50℃减压干燥。
本发明提供的头孢克洛化合物的精制方法，解决了目前技术合成的头孢克洛纯度低、杂质高的缺点，提高了临床制剂的质量，保障了用药的安全性；该方法工艺简单，操作方便，成本低，适合于规模化生产。
具体实施方式
以下通过具体实施方式进一步解释或说明本发明内容，但实施例不应被理解为对本发明保护范围的限制。
实施例1
向头孢克洛粗品100g中加入1mol/L的氢氧化钠溶液，调节pH值至9.1，充分反应至澄清，得头孢克洛钠盐溶液，然后经Hz816吸附树脂吸附，吸附完全后，用体积比为1∶1的异丙醇-水混合液洗脱头孢克洛钠盐，收集洗脱液，加入4g活性炭室温吸附30分钟，过滤脱碳，滤液加入1mol/L盐酸溶液，调节pH值至3.2，析出结晶，过滤，用乙醇洗涤，50℃减压干燥，得头孢克洛晶体94.2g，收率94.2％，HPLC检测纯度为99.8％。
实施例2
向头孢克洛粗品100g中加入2mol/L的氢氧化钾溶液，调节pH值至8.7，充分反应至澄清，得头孢克洛钾盐溶液，然后经AmberliteXAD-4吸附树脂吸附，吸附完全后，用体积比为1∶1的甲醇-水混合液洗脱头孢克洛钾盐，收集洗脱液，加入6g活性炭室温吸附20分钟，过滤脱碳，滤液加入2mol/L甲酸溶液，调节pH值至3.8，析出结晶，过滤，用乙醇洗涤，40℃减压干燥，得头孢克洛晶体92.5g，收率92.5％，HPLC检测纯度为99.9％。
实施例3
向头孢克洛粗品100g中加入5mol/L的乙酸钠溶液，调节pH值至8.8，充分反应至澄清，得头孢克洛钠盐溶液，然后经AmberliteXAD-4吸附树脂吸附，吸附完全后，用体积比为1∶1的乙腈-水混合液洗脱头孢克洛钠盐，收集洗脱液，加入10g活性炭室温吸附30分钟，过滤脱碳，滤液加入2mol/L硫酸溶液，调节pH值至3.5，析出结晶，过滤，用乙醇洗涤，45℃减压干燥，得头孢克洛晶体93.0g，收率93.0％，HPLC检测纯度为99.7％。
实施例4
向头孢克洛粗品100g中加入10％的碳酸氢钾溶液，调节pH值至8.6，充分反应至澄清，得头孢克洛钾盐溶液，然后经Hz816吸附树脂吸附，吸附完全后，用体积比为1∶1的丙酮-水混合液洗脱头孢克洛钾盐，收集洗脱液，加入5g活性炭室温吸附20分钟，过滤脱碳，滤液加入8mol/L乙酸溶液，调节pH值至3.6，析出结晶，过滤，用乙醇洗涤，47℃减压干燥，得头孢克洛晶体91.9g，收率91.9％，HPLC检测纯度为99.8％。
Claims (8)
1、一种式(I)所示结构的头孢克洛化合物及其制法，
其特征在于包括如下步骤：向头孢克洛粗品中加入碱性溶液中，调节pH值至8-10，充分反应至澄清，得头孢克洛盐溶液，然后经大孔吸附树脂吸附，吸附完全后，用洗脱剂洗脱头孢克洛盐，收集洗脱液，加活性炭吸附，过滤，滤液加入酸性溶液，调节pH值至3-4，析出结晶，过滤，洗涤，干燥，得头孢克洛晶体。
2、如权利要求1所述的头孢克洛化合物的精制方法，其特征在于碱性溶液可以为氨水、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、碳酸氢钠、碳酸氢钾、乙酸钠、乙酸钾、乙基己酸钠、三乙胺、二异丙基乙基胺、三丁胺、三乙醇胺或二甲基苄基胺。
3、如权利要求1所述的头孢克洛化合物的精制方法，其特征在于大孔吸附树脂为聚苯乙烯吸附树脂及其衍生树脂。
4、如权利要求3所述的头孢克洛化合物的精制方法，其特征在于大孔吸附树脂为Hz816吸附树脂或AmberliteXAD-4吸附树脂。
5、如权利要求1所述的头孢克洛化合物的精制方法，其特征在于洗脱剂为低碳有机溶剂-水混合液，选自甲醇-水混合液、乙腈-水混合液、丙酮-水混合液、乙醇-水混合液或异丙醇-水混合液。
6、如权利要求5所述的头孢克洛化合物的精制方法，其特征在于洗脱剂为体积比为1∶1的异丙醇-水混合液。
7、如权利要求1所述的头孢克洛化合物的精制方法，其特征在于酸性溶液选自盐酸、磷酸、硝酸、硫酸、柠檬酸、甲酸、乙酸溶液。
8、如权利要求1所述的头孢克洛化合物的精制方法，其特征在于析出结晶过滤后用乙醇洗涤，40-50℃减压干燥。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100149829A CN101550152B (zh) | 2009-05-07 | 2009-05-07 | 一种头孢克洛化合物及其制法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100149829A CN101550152B (zh) | 2009-05-07 | 2009-05-07 | 一种头孢克洛化合物及其制法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101550152A true CN101550152A (zh) | 2009-10-07 |
| CN101550152B CN101550152B (zh) | 2011-05-04 |
Family
ID=41154668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100149829A Expired - Fee Related CN101550152B (zh) | 2009-05-07 | 2009-05-07 | 一种头孢克洛化合物及其制法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101550152B (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102532166A (zh) * | 2010-12-27 | 2012-07-04 | 江苏九寿堂生物制品有限公司 | 一种精制头孢替唑酸制备方法 |
| CN109266713A (zh) * | 2018-11-12 | 2019-01-25 | 齐鲁安替制药有限公司 | 一种适用于工业生产的头孢克洛的制备方法 |
| CN111057072A (zh) * | 2019-12-16 | 2020-04-24 | 广州维奥康药业科技有限公司 | 一种头孢克洛杂质去除方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1251999B (it) * | 1991-11-11 | 1995-05-27 | Opos Biochimica Srl | Forma cristallina di un antibiotico cefalosporinico |
| CN101314605A (zh) * | 2008-06-12 | 2008-12-03 | 华东理工大学 | 从头孢克洛萘酚复合物中提纯头孢克洛的方法 |
-
2009
- 2009-05-07 CN CN2009100149829A patent/CN101550152B/zh not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102532166A (zh) * | 2010-12-27 | 2012-07-04 | 江苏九寿堂生物制品有限公司 | 一种精制头孢替唑酸制备方法 |
| CN109266713A (zh) * | 2018-11-12 | 2019-01-25 | 齐鲁安替制药有限公司 | 一种适用于工业生产的头孢克洛的制备方法 |
| CN111057072A (zh) * | 2019-12-16 | 2020-04-24 | 广州维奥康药业科技有限公司 | 一种头孢克洛杂质去除方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101550152B (zh) | 2011-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103539803B (zh) | 一种制备头孢曲松钠的方法 | |
| CN101544660A (zh) | 一种头孢克肟化合物及其制法 | |
| CN101948476B (zh) | 一种头孢替安酯盐酸盐的制备方法 | |
| CN101584671A (zh) | 一种头孢西酮钠药物粉针剂以及头孢西酮钠原料药的合成方法 | |
| CN101619069A (zh) | 一种头孢替安酯盐酸盐的制备方法 | |
| EP1612216B1 (en) | Process of purifying vancomycin hydrochloride | |
| CN101880289A (zh) | 一种头孢丙烯化合物及其制法 | |
| CN101550152B (zh) | 一种头孢克洛化合物及其制法 | |
| CN103102357B (zh) | 一种头孢呋辛钠的合成方法 | |
| CN102153566B (zh) | 头孢地尼的制备方法 | |
| CN101787036B (zh) | 一种高纯度的头孢孟多酯钠化合物 | |
| CN101550147B (zh) | 一种头孢地尼化合物及其制法 | |
| CN101941983A (zh) | 一种高纯度头孢西丁钠的制备方法 | |
| CN103360412B (zh) | 一种头孢羟氨苄的合成方法 | |
| CN101857601B (zh) | 一种高纯度的拉氧头孢钠化合物 | |
| CN101787039B (zh) | 一种高纯度的头孢美唑钠化合物 | |
| CN101550146A (zh) | 一种盐酸头孢他美酯化合物及其制法 | |
| CN109232610B (zh) | 一种头孢尼西二苄基乙二胺盐的精制方法 | |
| CN102796116B (zh) | 一种高纯度头孢唑肟钠的制备方法 | |
| CN101787037A (zh) | 一种高纯度的盐酸头孢替安化合物 | |
| CN102010428B (zh) | 头孢硫脒化合物及其新制法 | |
| CN102746324A (zh) | 一种盐酸头孢替安的纯化方法及盐酸头孢替安无菌粉针剂 | |
| CN101412715B (zh) | 一种氨曲南化合物及其制法 | |
| WO2013010297A1 (zh) | 纯化头孢唑肟钠的方法 | |
| CN107793432B (zh) | 头孢曲松钠粗盐的精制方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HAINAN MEIDA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHENG XIANFENG Effective date: 20130726 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250033 JINAN, SHANDONG PROVINCE TO: 570216 HAIKOU, HAINAN PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130726 Address after: 570216 C03, Haikou Free Trade Zone, Hainan, China Patentee after: Hainan Meida Pharmaceutical Co., Ltd. Address before: 801, room 1, unit 14, Luneng Cambridge area, Tianqiao District, Shandong, Ji'nan 250033, China Patentee before: Zheng Xianfeng |
|
| DD01 | Delivery of document by public notice |
Addressee: Zheng Xianfeng Document name: Notification of Passing Examination on Formalities |
|
| DD01 | Delivery of document by public notice |
Addressee: Hainan Meida Pharmaceutical Co., Ltd. Document name: Notification to Pay the Fees |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110504 Termination date: 20160507 |